scholarly journals Evaluation of Ischemia-Modified Albumin and C-Reactive Protein in Type 2 Diabetics with and without Ketosis

2012 ◽  
Vol 7 ◽  
pp. BMI.S9060 ◽  
Author(s):  
Shao-gang Ma ◽  
Yao Jin ◽  
Wen Hu ◽  
Feng Bai ◽  
Wen Xu ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Diabetic Patients ◽  
C Reactive Protein ◽  
Type 2 Diabetic Patients ◽  
Ischemia Modified Albumin ◽  
Protein Levels ◽  
Reactive Protein ◽  
Diabetic Ketosis ◽  
Type 2 Diabetics

Overview To investigate whether serum ischemia-modified albumin or C-reactive protein is reliable for predicting type 2 diabetic patients with ketosis. Approach One hundred and four diabetic patients, 48 with diabetic ketosis, and 33 controls were enrolled in the study. Serum ischemia-modified albumin and C-reactive protein were measured and evaluated for their ability to distinguish diabetic ketosis. Results Compared to the controls, the ischemia-modified albumin and C-reactive protein levels were higher in patients with diabetic ketosis and type 2 diabetes at the baseline. The levels of ischemia-modified albumin were higher in patients with type 2 diabetes than in the controls. C-reactive protein and ischemia-modified albumin levels were reduced after insulin treatment. The level of ischemia-modified albumin was an independent risk marker for diabetic ketosis ( OR = 1.085, P = 0.008, 95% CI: 1.022–1.152). Receiver operating characteristic curves revealed that the areas under the curve were 0.917 for the modified albumin and 0.357 for C-reactive protein. Conclusion This study indicates that ischemia-modified albumin was significantly associated with diabetic ketosis and was more sensitive than C-reactive protein in reflecting diabetic ketosis.

Rosiglitazone Reduces Insulin Requirement and C-Reactive Protein Levels in Type 2 Diabetic Patients Receiving Peritoneal Dialysis

2005 ◽  
Vol 46 (4) ◽  
pp. 713-719 ◽  
Author(s):  
Teresa Yuk-Hwa Wong ◽  
Cheuk-Chun Szeto ◽  
Kai-Ming Chow ◽  
Chi-Bong Leung ◽  
Christopher Wai-Kei Lam ◽  
...  
Keyword(s):  
Peritoneal Dialysis ◽  
Insulin Requirement ◽  
Diabetic Patients ◽  
C Reactive Protein ◽  
Type 2 Diabetic Patients ◽  
Protein Levels ◽  
Reactive Protein ◽  
Type 2 Diabetic

Retinopathy and hypertension affect serum high-sensitivity C-reactive protein levels in Type 2 diabetic patients

2005 ◽  
Vol 19 (3) ◽  
pp. 123-127 ◽  
Author(s):  
Keiko Tsunoda ◽  
Mikio Arita ◽  
Mariko Yukawa ◽  
Minoru Ueyama ◽  
Machi Furuta ◽  
...  
Keyword(s):  
High Sensitivity ◽  
Diabetic Patients ◽  
C Reactive Protein ◽  
Type 2 Diabetic Patients ◽  
Protein Levels ◽  
Reactive Protein ◽  
Type 2 Diabetic

scholarly journals Rosiglitazone lowers C-reactive protein levels in hypertensive type 2 diabetic patients

2005 ◽  
Vol 18 (5) ◽  
pp. A244-A244
Author(s):  
P SARAFIDIS ◽  
A LASARIDIS ◽  
P STAFILAS ◽  
K MAKEDOUKOURTI ◽  
P ZEBEKAKIS ◽  
...  
Keyword(s):  
Diabetic Patients ◽  
C Reactive Protein ◽  
Type 2 Diabetic Patients ◽  
Protein Levels ◽  
Reactive Protein ◽  
Type 2 Diabetic

scholarly journals C-Reactive Protein and Cholesterol level In Male Type 2 Diabetic Patients.

2012 ◽  
Vol 9 (1) ◽  
pp. 113-119
Author(s):  
Baghdad Science Journal
Keyword(s):  
Type 2 Diabetes ◽  
Control Group ◽  
Diabetic Patients ◽  
C Reactive Protein ◽  
Type 2 Diabetic Patients ◽  
Reactive Protein ◽  
Male Type ◽  
Group A ◽  
Group B

Elevated C-Reactive Protein (CRP) level in serum is a risk factor for type 2 diabetes ,this relationship is likely to be the cause it means elevated CRP leads to T2D in future . Our objective was to examine CRP in male Type 2 Diabetes(T2D) patients in different age ,we studied 120 male subjects divided to two groups according to their age. First group A age (31 - 40) year old ,60 person )30 control & 30 T2D patients(,3 person for each same age: second group B age (41 – 50) years old ,60 person )30 control & 30 T2D patients(,3 person for each same age. We examined blood sugar ,cholesterol and CRP in each group. and we toke the mean of samples in the same age in each data in all the 4 groups. Our data shows that CRP raised significantly P?0.05 in group A(T2D) and in group B(T2D) comparing with control group of each .And cholesterol levels, and sugar levels raised significantly P?0.05 in group A(T2D) and in group B(T2D) comparing with control group of each. CRP ,Cholesterol and sugar are higher in group B(T2D) than in group A(T2D),and in group B (control) than in group A (control). CRP level can predict diabetes but not causal, diabetes may cause a kind of inflammation (showed by high CRP) by its effect on body and this effect (inflammation) may cause rising CRP level.

Sign in / Sign up

Export Citation Format

Share Document